학술논문

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
Document Type
article
Source
Nature Genetics. 49(2)
Subject
Human Genome
Digestive Diseases
Autoimmune Disease
Digestive Diseases - (Gallbladder)
Genetics
Rare Diseases
Inflammatory Bowel Disease
2.1 Biological and endogenous factors
Aetiology
Oral and gastrointestinal
Adaptor Proteins
Signal Transducing
Alleles
Cholangitis
Sclerosing
Colitis
Ulcerative
Genome-Wide Association Study
Humans
Inflammatory Bowel Diseases
Polymorphism
Single Nucleotide
RNA
Messenger
Risk Factors
UK-PSC Consortium
International IBD Genetics Consortium
International PSC Study Group
Biological Sciences
Medical and Health Sciences
Developmental Biology
Language
Abstract
Primary sclerosing cholangitis (PSC) is a rare progressive disorder leading to bile duct destruction; ∼75% of patients have comorbid inflammatory bowel disease (IBD). We undertook the largest genome-wide association study of PSC (4,796 cases and 19,955 population controls) and identified four new genome-wide significant loci. The most associated SNP at one locus affects splicing and expression of UBASH3A, with the protective allele (C) predicted to cause nonstop-mediated mRNA decay and lower expression of UBASH3A. Further analyses based on common variants suggested that the genome-wide genetic correlation (rG) between PSC and ulcerative colitis (UC) (rG = 0.29) was significantly greater than that between PSC and Crohn's disease (CD) (rG = 0.04) (P = 2.55 × 10-15). UC and CD were genetically more similar to each other (rG = 0.56) than either was to PSC (P < 1.0 × 10-15). Our study represents a substantial advance in understanding of the genetics of PSC.